Annovis Bio (ANVS)

• Market cap: $80.6M
• 1 day: -7.57%
• 5 days: -6.95%
• 1 month: -19.71%
• 3 months: 27.73%
• 6 months: 5.64%
• Year to date: -23.01%
• 1 year: -42.54%
• 5 years: -71.84%
• 10 years: -70.7%
• Sector: Healthcare
• Industry: Biotechnology

About: Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Employees: 6